You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

FLUXID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Fluxid patents expire, and when can generic versions of Fluxid launch?

Fluxid is a drug marketed by Ucb Inc and is included in one NDA.

The generic ingredient in FLUXID is famotidine. There are eighteen drug master file entries for this compound. One hundred and thirty-five suppliers are listed for this compound. Additional details are available on the famotidine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fluxid

A generic version of FLUXID was approved as famotidine by FRESENIUS KABI USA on April 16th, 2001.

  Try a Trial

US Patents and Regulatory Information for FLUXID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc FLUXID famotidine TABLET, ORALLY DISINTEGRATING;ORAL 021712-001 Sep 24, 2004 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ucb Inc FLUXID famotidine TABLET, ORALLY DISINTEGRATING;ORAL 021712-002 Sep 24, 2004 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FLUXID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc FLUXID famotidine TABLET, ORALLY DISINTEGRATING;ORAL 021712-001 Sep 24, 2004 ⤷  Try a Trial ⤷  Try a Trial
Ucb Inc FLUXID famotidine TABLET, ORALLY DISINTEGRATING;ORAL 021712-001 Sep 24, 2004 ⤷  Try a Trial ⤷  Try a Trial
Ucb Inc FLUXID famotidine TABLET, ORALLY DISINTEGRATING;ORAL 021712-002 Sep 24, 2004 ⤷  Try a Trial ⤷  Try a Trial
Ucb Inc FLUXID famotidine TABLET, ORALLY DISINTEGRATING;ORAL 021712-002 Sep 24, 2004 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for FLUXID

See the table below for patents covering FLUXID around the world.

Country Patent Number Title Estimated Expiration
Japan 2012162558 RAPIDLY DISSOLVING ROBUST DOSAGE FORM ⤷  Try a Trial
European Patent Office 2147669 Formule de dosage robuste à dissolution rapide (Rapidly dissolving robust dosage form) ⤷  Try a Trial
Australia 6896998 ⤷  Try a Trial
Spain 2525720 ⤷  Try a Trial
Denmark 2266538 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 9846215 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.